1999Chinese Journal of New Drugs and Clinical RemediesRequires access

Amlodipine vs nifedipine in treating aged with simple systolic hypertension

Zhi Liu

Open publisher page 0 citations

Abstract

AIM: To compare the effects of amlodipine and nifedipine in treating aged with simple systolic hypertension. METHODS: Thirty_four patients (M 20, F 14; age 68.8 a±s 1.2 a) received amlodipine 5_10 mg, po, qd for 8 wk. Another 34 patients (M 18, F 16; age 67.8 a±1.3 a) received nifedipine 10_20 mg, po, tid for 8 wk. RESULTS: The clinical total effective rate of amlodipine group was 94%, without significant difference with that of the nifedipine group (91%) (P0.05). Adverse reactions of amlodipine group were fewer than those of nifedipine group (12% vs 24%, P0.01). CONCLUSION: Amlodipine is a safe and effective drug. It is superior to nifedipine in treating aged with systolic hypertension.

About this research paper

What this paper is about

AIM: To compare the effects of amlodipine and nifedipine in treating aged with simple systolic hypertension. METHODS: Thirty_four patients (M 20, F 14; age 68.8 a±s 1.2 a) received amlodipine 5_10 mg, po, qd for 8 wk. Another 34 patients (M 18, F 16; age 67.8 a±1.3 a) received nifedipine 10_20 mg, po, tid for 8 wk. RESULTS: The clinical total effective rate of amlodipine group was 94%, without significant difference with that of the nifedipine group (91%) (P0.05). Adverse reactions of amlodipine group were fewer than those of nifedipine group (12% vs 24%, P0.01). CONCLUSION: Amlodipine is a safe and effective drug. It is superior to nifedipine in treating aged with systolic hypertension.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To compare the effects of amlodipine and nifedipine in treating aged with simple systolic hypertension. METHODS: Thirty_four patients (M 20, F 14; age 68.8 a±s 1.2 a) received amlodipine 5_10 mg, po, qd for 8 wk. Another 34 patients (M 18, F 16; age 67.8 a±1.3 a) received nifedipine 10_20 mg, po, tid for 8 wk. RESULTS: The clinical total effective rate of amlodipine group was 94%, without significant difference with that of the nifedipine group (91%) (P0.05). Adverse reactions of amlodipine group were fewer than those of nifedipine group (12% vs 24%, P0.01). CONCLUSION: Amlodipine is a safe and effective drug. It is superior to nifedipine in treating aged with systolic hypertension.

Key concepts: Nifedipine, Amlodipine, Medicine, Adverse effect, Blood pressure, Significant difference, Isolated systolic hypertension, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Amlodipine vs nifedipine in treating aged with simple systolic hypertension — Research Paper | ScholarLens